öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÕž­Î³
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º229

ËùÊôԺУ£ºÖйúÒ©¿Æ´óѧ
ËùÊôԺϵ£ºÒ©Îï¿ÆѧÑо¿Ôº
Ö°³Æ£º¸±Ñо¿Ô±
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Ñ§£¨Ò©Îï´úл¶¯Á¦Ñ§£©
Ñо¿ÁìÓò£º 1¡¢Ò©Îï´úлø/תÔËÌå±í´ïµ÷¿Ø»úÖÆÑо¿2¡¢´´ÐÂÒ©ÎïµÄÒ©Îï´úл¶¯Á¦Ñ§Ñо¿
Ñо¿ÁìÓò£º 1¡¢Ò©Îï´úлø/תÔËÌå±í´ïµ÷¿Ø»úÖÆÑо¿2¡¢´´ÐÂÒ©ÎïµÄÒ©Îï´úл¶¯Á¦Ñ§Ñо¿ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºzhangjw_cnnj@sina.com
ͨѶµØÖ·£ºÖйúÒ©¿Æ´óѧ ÐþÎäÃÅУÇø ¿ÆÑдóÂ¥ 803


¸öÈ˼òÊö :
Õž­Î³£¬Ò©Îï¿ÆѧÑо¿Ôº£¬²©Ê¿£¬¸±Ñо¿Ô±£¬Ë¶Ê¿Éúµ¼Ê¦¡£2006Äê±ÏÒµÓÚÖйúÒ©¿Æ´óѧ»ù´¡Ò©Ñ§Àí¿Æ»ùµØ°à£¬»ñµÃѧʿѧλ¡£±ÏҵʱÃâÊÔÍƼöÖÁÖйúÒ©¿Æ´óѧҩÎï´úл¶¯Á¦Ñ§ÖصãʵÑéÊÒÖ±½Ó¹¥¶Á²©Ê¿Ñ§Î»£¬Ê¦´ÓÍõ¹ã»ùԺʿ¡£²©Ê¿±ÏÒµÂÛÎÄ»ñ2012Äê¶È½­ËÕÊ¡ÓÅÐ㲩ʿÂÛÎÄ¡£²©Ê¿±ÏÒµºóÁôУ¹¤×÷£¬Ö÷Òª´ÓÊÂϸ°ûÒ©´ú¶¯Á¦Ñ§¡¢·Ö×ÓÒ©Àíѧ¡¢ÖÐÒ©/´´ÐÂÒ©ÎïµÄÒ©´ú¶¯Á¦Ñ§µÈÑо¿¹¤×÷£¬²àÖØÓÚϸ°ûÒ©´ú¶¯Á¦Ñ§Ñо¿ÌåϵµÄ½¨Á¢¼°Ó¦Óã¬Ò©Îï´úлø/תÔËÌå±í´ïµ÷¿Ø»úÖÆÑо¿µÈ¡£½ü¼¸ÄêÀ´Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿1Ïî¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄê»ù½ð1Ïî¡¢½­ËÕÊ¡×ÔÈ»¿Æѧ»ù½ðÓÅÐãÇàÄê»ù½ð1Ïî¡¢½­ËÕÊ¡×ÔÈ»¿Æѧ»ù½ðÇàÄê»ù½ð1Ïî¡¢½ÌÓý²¿ÖÐÑë¸ßУ»ù±¾¿ÆÑÐÒµÎñ·ÑרÏî×ÊÖú£¨ÅàÓýÏîÄ¿£©1ÏÏȺó²Î¼Ó¹ú¼ÒÐÂÒ©´´ÖÆÖØ´óרÏî¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÖصãÏîÄ¿¡¢ÃæÉÏÏîÄ¿5Ïͬʱ¸ºÔð¶à¸öºáÏò¿ÎÌâÑо¿¡£ÏȺóÒÔµÚÒ»×÷Õß/ͨѶ×÷Õß·¢±íSCIÂÛÎÄ10ƪ¡£?

¿ÆÑй¤×÷ :
Ö÷ÒªÑо¿³É¹û£º1. Liu J, Zhou F, Chen Q, Kang A, Lu M, Liu W, Zang X, Wang G*, Zhang J*. Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-¦Êb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice. Sci Rep. 20155:13558. 2. Lu M, Zhou F, Hao K, Liu J, Chen Q, Ni P, Zhou H, Wang G*, Zhang J*. Alternation of adriamycin penetration kinetics in MCF-7 cells from 2D to 3D culture based on P-gp expression through the Chk2/p53/NF-¦ÊB pathway. Biochem Pharmacol. 201593(2):210-20.3. Jingwei Zhang, Jiali Liu, Yanlei Zhao, Guangji Wang*, and Fang Zhou*. Plasma and cellular pharmacokinetics considerations for the development and optimization of anti-tumor block copolymer micelles. Expert Opin Drug Deliv, 201512(2):263-814. Zhang J, Sun Y, Wang Y, Lu M, He J, Liu J, Chen Q, Zhang X, Zhou F*, Wang G*, Sun X. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor. Eur J Pharmacol. **:277-84.5. Jingwei Zhang, Meng Lu, Fang Zhou, Haopeng Sun, Gang Hao, Xiaolan Wu, Guangji Wang*. Key Role of Nf-¦ÊB in Cellular Pharmacokinetics of Adriamycin in MCF-7/Adr Cells: The Potential Synergistic Mechanism for 20(S)-Ginsenoside Rh2. Drug Metab Dispos, 2012,40(10):1900-86. Jingwei Zhang Fang Zhou Meng Lu Wei Ji Fang Niu Weibin Zha Xiaolan Wu Haiping Hao Guangji Wang*. Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and Its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy. Current Drug Metab, 2012, 13(5):558-767. Jingwei Zhang Fang Zhou Fang Niu Meng Lu Xiaolan Wu Jianguo Sun Guangji Wang*. Stereoselective Regulations of P-glycoprotein by Ginsenoside Rh2 Epimers and the Potential Mechanisms From the View of Pharmacokinetics. Plos One, 2012, 7(4):e357688. Jingwei Zhang Fang Zhou Xiaolan Wu Xiaoxuan Zhang Yuancheng Chen BS Zha Fang Niu Meng Lu Gang Hao Yuan Sun Jianguo Sun Ying Peng Guangji Wang*. Cellular Pharmacokinetic Mechanisms of Adriamycin Resistance and Its Modulation by 20(S)-Ginsenoside Rh2 in MCF-7/Adr Cells. Br J Pharmacol, 2012, 165(1):120-1349. Jingwei Zhang Fang Zhou Xiaolan Wu Yi Gu Hua Ai Yuanting Zheng Yannan Li Xiaoxuan Zhang Gang Hao Jianguo Sun Ying Peng Guangji Wang*. 20(S)-Ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in viv a case for herb-drug interactions. Drug Metab Dispos, 2010, 38(12): 2179-2187